Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT

Magnetic Resonance in Medicine

Volumn 63, Issue 6, 2010, Pages 1601-1609

  Yang, Cheng ^a   Stadler, Walter M ^a   Karczmar, Gregory S ^a   Milosevic, Michael ^b,c   Yeung, Ivan ^b,c   Haider, Masoom A ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Correlation; Dynamic contrast enhanced CT; Dynamic contrast enhanced MRI; Quantitative analysis; T1 MRI; Tracer kinetic modeling

Indexed keywords

BLOOD; CHEMICAL ANALYSIS; CORRELATION METHODS; DISEASES; MAGNETIC RESONANCE IMAGING; POPULATION STATISTICS; RATE CONSTANTS; TISSUE ENGINEERING; TUMORS;

ARTERIAL INPUT FUNCTION; CORRELATION COEFFICIENT; DYNAMIC CONTRAST ENHANCED; DYNAMIC CONTRAST ENHANCED MRI; DYNAMIC CONTRAST ENHANCED MRIS (DCE); LOW MOLECULAR WEIGHT; QUANTITATIVE PARAMETERS; TRACER KINETIC MODELING;

COMPUTERIZED TOMOGRAPHY;

GADODIAMIDE; IOHEXOL; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARAMETERS OF MEASUREMENT AND ANALYSIS; PLASMA VOLUME; QUANTITATIVE ANALYSIS; REFERENCE VALUE; UTERINE CERVIX CANCER; ARTIFACT; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; MIDDLE AGED; RADIOGRAPHY; TUMOR VOLUME; UTERINE CERVIX TUMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARTIFACTS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IOHEXOL; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 77952717228     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22371     Document Type: Article

References (40)

1. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 2002;16: 407-422.
2. Morgan B, Thomas AL, Drevs J, Hennig J, Buchert M, Jivan A, Horsfield MA, Mross K, Ball HA, Lee L, Mietlowski W, Fuxuis S, Unger C, O'Byrne K, Henry A, Cherryman GR, Laurent D, Dugan M, Marme D, Steward WP. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol 2003;21:3955-3964. (Pubitemid 46606209)
3. Liu G, Rugo HS, Wilding G, McShane TM, Evelhoch JL, Ng C, Jackson E, Kelcz F, Yeh BM, Lee FT Jr, Charnsangavej C, Park JW, Ashton EA, Steinfeldt HM, Pithavala YK, Reich SD, Herbst RS. Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. J Clin Oncol 2005;23:5464-5473. (Pubitemid 46300139)
4. Miles KA, Functional CT imaging in oncology. Eur Radiol 2003; 13(suppl 5):M134-138.
5. Hahn OM, Yang C, Medved M, Karczmar G, Kistner E, Karrison T, Manchen E, Mitchell M, Ratain MJ, Stadler WM. Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma. J Clin Oncol 2008; 26:4572-4578.
6. Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 2004;10: 145-147. (Pubitemid 38524883)
7. Sahani DV, Kalva SP, Hamberg LM, Hahn PF, Willett CG, Saini S, Mueller PR, Lee TY. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology 2005;234:785-792. (Pubitemid 40250822)
8. Bellomi M, Petralia G, Sonzogni A, Zampino MG, Rocca A. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology 2007;244: 486-493. (Pubitemid 47080881)
9. Goh V, Halligan S, Wellsted DM, Bartram CI. Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study. Eur Radiol 2009;19:79-89.
10. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10: 223-232.
11. Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson GC, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin GJ, Tofts PS, Tozer GM, Vennart W, Waterton JC, Williams SR, Workman P. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 2005;92:1599-1610. (Pubitemid 40756468)
12. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95.
13. Wagner JA. Strategic approach to fit-for-purpose biomarkers in drug development. Annu Rev Pharmacol Toxicol 2008;48:631-651. (Pubitemid 351738166)
14. Chau CH, Rixe O, McLeod H, Figg WD. Validation of analytic methods for biomarkers used in drug development. Clin Cancer Res 2008; 14:5967-5976.
15. Wendland MF, Saeed M, Yu KK, Roberts TP, Lauerma K, Derugin N, Varadarajan J, Watson AD, Higgins CB. Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement. Magn Reson Med 1994;32:319-329. (Pubitemid 24274910)
16. Ivancevic MK, Zimine I, Foxall D, Lecoq G, Righetti A, Didier D, Vallee JP. Inflow effect in first-pass cardiac and renal MRI. J Magn Reson Imaging 2003;18:372-376. (Pubitemid 37046522)
17. Ivancevic MK, Zimine I, Montet X, Hyacinthe JN, Lazeyras F, Foxall D, Vallee JP. Inflow effect correction in fast gradient-echo perfusion imaging. Magn Reson Med 2003;50:885-891. (Pubitemid 37356567)
18. Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of GdDTPA/ dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984;16:167-172.
19. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging, 1: fundamental concepts. Magn Reson Med 1991;17:357-367.
20. Parker GJ, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, Buckley DL, Jackson A, Watson Y, Davies K, Jayson GC. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006;56:993-1000. (Pubitemid 44691341)
21. Yang C, Karczmar GS, Medved M, Stadler WM. Estimating the arterial input function using two reference tissues in dynamic contrast-enhanced MRI studies: fundamental concepts and simulations. Magn Reson Med 2004;52:1110-1117. (Pubitemid 39453285)
22. Yang C, Karczmar GS, Medved M, Stadler WM. Multiple reference tissue method for contrast agent arterial input function estimation. Magn Reson Med 2007;58:1266-1275. (Pubitemid 350234214)
23. Yang C, Karczmar GS, Medved M, Oto A, Zamora M, Stadler WM. Reproducibility assessment of a multiple reference tissue method for quantitative dynamic contrast enhanced-MRI analysis. Magn Reson Med 2009;61:851-859.
24. Brix G, Bahner ML, Hoffmann U, Horvath A, Schreiber W. Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT: initial experience. Radiology 1999; 210:269-276. (Pubitemid 29004315)
25. Miles KA, Griffiths MR. Perfusion CT: a worthwhile enhancement? Br J Radiol 2003;76:220-231.
26. Gierada DS, Bae KT. Gadolinium as a CT contrast agent: assessment in a porcine model. Radiology 1999;210:829-834.
27. Miles KA, Griffiths MR, Fuentes MA. Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules. Radiology 2001;220:548-553.
28. Medved M, Karczmar G, Yang C, Dignam J, Gajewski TF, Kindler H, Vokes E, MacEneany P, Mitchell MT, Stadler WM. Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: variability and changes in tumor tissue over time. J Magn Reson Imaging 2004;20:122-128. (Pubitemid 38857525)
29. Bydder GM, Hajnal JV, Young IR. Use of the inversion recovery pulse sequence. In: Stark DD, Bradley WG, editors. Magnetic resonance imaging. St. Louis: William G. Mosby; 1999. p 69-86.
30. Haider MA, Milosevic M, Fyles A, Sitartchouk I, Yeung I, Henderson E, Lockwood G, Lee TY, Roberts TP. Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements. Int J Radiat Oncol Biol Phys 2005;62:1100-1107. (Pubitemid 40884424)
31. Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radiology 2003;227:617-622.
32. Ludman PF, Darby M, Tomlinson N, Poole-Wilson PA, Rees S. Cardiac flow measurement by ultrafast CT: validation of continuous and pulsatile flow. J Comput Assist Tomogr 1992;16: 795-803.
33. Takanami K, Higano S, Takase K, Kaneta T, Yamada T, Ishiya H, Mori I, Takahashi S. Validation of the use of calibration factors between the iodine concentration and the computed tomography number measured outside the objects for estimation of iodine concentration inside the objects: phantom experiment. Radiat Med 2008; 26:237-243. (Pubitemid 351754728)
34. Stanisz GJ, Henkelman RM. Gd-DTPA relaxivity depends on macro-molecular content. Magn Reson Med 2000;44:665-667.
35. Nyman U, Elmstahl B, Leander P, Nilsson M, Golman K, Almen T. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 2002;223:311-318.
36. Olsson B, Aulie A, Sveen K, Andrew E. Human pharmacokinetics of iohexol: a new nonionic contrast medium. Invest Radiol 1983;18: 177-182. (Pubitemid 13111342)
37. Van Wagoner M, Worah D. Gadodiamide injection: first human experience with the nonionic magnetic resonance imaging enhancement agent. Invest Radiol 1993;28(suppl 1):S44-48.
38. Remy-Jardin M, Dequiedt P, Ertzbischoff O, Tillie-Leblond I, Bruzzi J, Duhamel A, Remy J. Safety and effectiveness of gadolinium-enhanced multi-detector row spiral CT angiography of the chest: preliminary results in 37 patients with contraindications to iodinated contrast agents. Radiology 2005;235:819-826. (Pubitemid 40695875)
39. Remy-Jardin M, Bahepar J, Lafitte JJ, Dequiedt P, Ertzbischoff O, Bruzzi J, Delannoy-Deken V, Duhamel A, Remy J. Multi-detector row CT angiography of pulmonary circulation with gadolinium-based contrast agents: prospective evaluation in 60 patients. Radiology 2006;238:1022-1035. (Pubitemid 43289935)
40. Bisdas S, Medov L, Baghi M, Konstantinou GN, Wagenblast J, Thng CH, Vogl TJ, Koh TS. A comparison of tumour perfusion assessed by deconvolution-based analysis of dynamic contrast-enhanced CT and MR imaging in patients with squamous cell carcinoma of the upper aerodigestive tract. Eur Radiol 2008; 18:843-850.